Skip to Main

Search

Results 931 to 940 of 1,037 for ""

Roughly 6,000 UT Southwestern caregivers receive COVID-19 vaccine: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/caregivers-receive-vaccine.html

Nearly 6,000 front-line health care workers at UT Southwestern have received initial doses of the COVID-19 vaccine since the Medical Center received its first shipment of 5,850 doses on Dec. 15.

Scientists weigh in on debate to quash daylight saving: Newsroom, UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/daylight-saving.html

Dr. Joseph Takahashi, who discovered the first circadian gene in mammals (CLOCK), points out that desynchronized body clocks are linked to greater health risks such as obesity, heart attack, cancer, and depression.

Dr. Takahashi receives global award for pioneering work on circadian rhythms: Newsroom, UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/takahashi-circadian-rhythms-award.html

Dr. Joseph S. Takahashi has received an international award for his pioneering work on the molecular and genetic bases of circadian rhythms in mammals.

UT Southwestern and Children’s Health receive record-setting gift from Moody Foundation : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/may-pediatrics-campus-gift-moody-foundation.html

UT Southwestern Medical Center and Children’s Health℠ today announced a historic nine-figure grant from the Moody Foundation to support the new $5 billion pediatric campus in Dallas, which broke ground in October 2024. The new hospital will help meet the increasing demand for pediatric health care

Chen, Hooper elected to National Academy of Medicine: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/october-national-academy-of-medicine.html

The National Academy of Medicine announced the election of two UT Southwestern Medical Center faculty members – Lora Hooper, Ph.D., Chair of Immunology, and Zhijian “James” Chen, Ph.D., Professor of Molecular Biology and Director of the Center for Inflammation Research.

UTSW Medical Student Dean selected for prestigious Piper Professor Award for educators: Newsroom, UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/piper-professor-award.html

Dr. Angela Mihalic, Dean of Medical Students and Associate Dean of Student Affairs, has been selected to receive the 2019 Minnie Stevens Piper Foundation’s Piper Professor Award, a prestigious honor that recognizes outstanding college professors across Texas.

UT Southwestern campaign infuses $1B into Peter O’Donnell Jr. Brain Institute : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/obi-philanthropic-campaign.html

UT Southwestern Medical Center has completed a five-year, $1 billion campaign to fuel its commitment to advance brain research and clinical care at its Peter O’Donnell Jr. Brain Institute, making it one of the largest brain-focused investments at a U.S. academic medical center.

Newsroom Archive: 2023 - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/

Stories published in 2023 about UT Southwestern Medical Center.

Magnetic fields kill bacteria that infect medical implants: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/feb-magnetic-fields-kill-bacteria.html

UT Southwestern Medical Center is collaborating with Pfizer Inc. to develop RNA enhanced delivery technologies for genetic medicine therapies through the Dallas-based medical center’s Program in Genetic Drug Engineering.

Biomarkers linked to side effects from cancer immunotherapy

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-immunotherapy-biomarkers.html

A team led by UT Southwestern Medical Center scientists has identified early signals from the immune system that could help predict which cancer patients are most likely to develop harmful side effects from immunotherapy.